Becton, Dickinson and Company (BDX)

BDX Revenue by Segment

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Medical	10.77B	10.46B	10.07B	9.79B	9.67B	9.58B	9.50B	8.79B
Medical Growth	11.41%	9.20%	6.02%	11.45%	13.17%	11.40%	7.48%	-7.88%
Life Sciences	5.14B	5.20B	5.19B	5.18B	5.15B	5.12B	5.13B	5.09B
Life Sciences Growth	-0.10%	1.58%	1.13%	1.81%	-0.48%	-4.90%	-7.75%	-12.38%
Interventional	5.02B	5.05B	4.98B	4.92B	4.90B	4.80B	4.74B	4.63B
Interventional Growth	2.45%	5.30%	5.15%	6.35%	7.64%	7.08%	6.09%	4.28%

Revenue by Geography

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
United States	12.20B	11.99B	11.66B	11.43B	11.31B	11.13B	11.11B	10.65B
United States Growth	7.88%	7.74%	4.95%	7.24%	7.41%	5.03%	3.65%	-4.07%
International	8.67B	8.65B	8.52B	8.40B	8.41B	8.36B	8.26B	7.85B
International Growth	3.12%	3.45%	3.11%	7.00%	8.59%	6.34%	1.35%	-9.49%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.